CBRE vs TTRX · P/E 43, rev $21.75B vs $187.1M cap
CBRE Group Inc Class A (CBRE) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
TTRX does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the CBRE and TTRX stock pages for the full models.
Not investment advice.